AnnouncementsSuven Life Sciences secures three product patents
AnnouncementsSuven Life secures three product patents for their NCEs
No recommendations so far.What's your call on Suven Life Sci today? Read Investor view
|Company Name||Last Price||%
|Dr Reddys Labs||2556.00||0.66||2939.80||1904.15||43,479.83|
|Dec' 13||Jun' 13||Mar' 13||Dec' 12|
|No Mutual Funds Holding the share|
Suven Life Sci is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 876.22 crore.The company has reported a standalone sales of Rs 119.43 crore and a Net Profit of Rs 36.43 crore for the quarter ended Dec 2013.
The company management includes Venkateswarlu Jasti - Chairman & CEO, Sudha Rani Jasti - Whole Time Director, M R Naidu - Director, K V Raghavan - Director, D G Prasad - Director, Syed E Hasnain - Director, M Gopala Krishna - Additional Director.
It is listed on the BSE with a BSE Code of 530239 and the NSE with an NSE Code of SUVEN.
Its Registered office is at Serene Chambers, 6th Floor, Road No. 5,,Avenue 7, Hyderabad,Andhra Pradesh - 500034.
Their Registrars are Karvy Computershare Private Ltd.